Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Phase III Clinical Trials Pooled Analysis Results. (2017). SKIN The Journal of Cutaneous Medicine, 1(3.1), s102. https://doi.org/10.25251/skin.1.supp.101